Glycosyl-phosphatidylinositol molecules, acting as both signal transduction elements and membrane protein anchors, have been proposed to play a role during T-cell activation. The MVB2 cell line is a mutant, derived from the wild-type T-T hybrid YH.16.33, which has a defect in the biosynthesis of Ptdlns-protein linkages. As a consequence, MVB2 mutants are defective in activation through the T-cell receptor. Despite the lack of glycosyl-Ptdlns anchors in the mutant MVB2 cells, a comparison of the levels and structural features of the insulin-sensitive glycosyl-Ptdlns between the MVB2 and YH. 16.33 lineages indicates that both cell lines are identical in this respect. The time course for insulin-responsiveness coincides in both cell lines, with maximal hydrolysis 30 s after insulin addition. The ultimate localization of insulinregulated glycosyl-Ptdlns at the outer surface of the cell membrane is also similar. These data indicate that the glycosylPtdlns whose hydrolysis is regulated by insulin is not anchoring proteins at the cell surface of T-lymphocytes.
INTRODUCTION
Glycosyl-phosphatidylinositol molecules display important dual functions in eukaryotic cells, as membrane anchors of covalently attached proteins [1, 2] and as precursors to the inositol phospho-oligosaccharide (IPG), a putative mediator of insulin action [3, 4] . A variety of proteins which play a role during T-cell activation are anchored to the cell surface by a glycosyl-Ptdlns linkage, e.g. the T-cell-activating protein (TAP), Thy-1 and other Ly-6 proteins [5] . MVB2 cells are mutant T-lymphocyte clones with defects in the assembly of glycosyl-Ptdlns-TAP. This mutation greatly affects the immune responsiveness of these clones when compared with the parental line YH. 16 .33. These results strongly support a role for glycoproteins linked through a glycosyl-Ptdlns anchor to the cell surface in physiological Tcell activation [6, 7] . The anchorage functions are not yet fully understood, but these molecules may transmit activation signals, and their physiological functions may thus involve membrane interactions in addition to those of protein attachment to the bilayer. In this context, it has been proposed that glycosyl-Ptdlns linkages are also the precursor molecules of IPG [8] . In this model, insulin would stimulate a Ptdlns-specific phospholipase C (Ptdlns-PLC) and a proteinase, with liberation of protein, IPG and diacylglycerol, all of which will serve a different biological function. This hypothesis is questioned, however, by the finding that these glycosyl-Ptdlns molecules may exhibit different chemical compositions [1, 9] , and definitive data supporting such regulation have not been reported.
The insulin receptor, together with interleukin-2 and transferrin receptors, is one of a group of early response genes that are expressed following mitogen or antigen stimulation of T-lymphocytes [10] . The binding of each of these growth factors is essential for optimal T-cell proliferation, and even for cellular differentiation. A role for glycosyl-Ptdlns molecules as precursors to insulin and interleukin-2 signal transduction elements in lymphocytes has been recently proposed [11] [12] [13] .
In this paper we present the chemical composition, biosynthesis and final localization of insulin-regulated glycosyl-Ptdlns in Tlymphocyte mutant clones with defects in the synthesis of the Ptdlns-protein linkage. Our (21.7 Ci/mmol), [9,10-3H] myristic acid (22.4 Ci/mmol), [9,10-3H] palmitic acid (28.5 Ci/mmol) and [5,6,8,9,11,12,14,1 5-3H] arachidonic acid (238 Ci/mmol) were from New England Nuclear.
Cell culture
The mouse T-T hybridoma YH. 16 .33 (wild-type hybrid) and the glycosyl-Ptdlns-protein-linkage deficient mutant MVB2 cell lines were a gift from Dr. K. L. Rock (Harvard Medical School, Boston, MA, U.S.A.) [6] . Cells were grown in Dulbecco's modified Eagle's medium containing 10°fetal calf serum, 2mM-L-glutamine, 100 units of penicillin/ml and 100,ug of streptomycin/ml at 37°C in air/CO2 (19:1) . Culture medium and additives were from Flow Laboratories. Cultures were typically seeded at I x 105/ml and grown for 48 h to densities of approx. 1 x 106/ml. Before use, lymphocytes were harvested by centrifugation (1000 g for 6 min), washed twice and resuspended in 5 mM-sodium phosphate, pH 7.4, containing 150 mM-NaCl. [9] . Briefly, the trichloroacetic acid treatment was followed by a low-speed centrifugation, the pellets were extracted with 1. Further analysis of glucosamine-labelled peak III from either cell line was achieved by its elution from the silica and application to a third thin layer plate for two-dimensional chromatography, followed by fluorographic detection of the labelled glycosylPtdlns. As shown in Figs. 2(a) and 2(b) , a single spot was apparent, indicating that under these conditions [3H]glucosamine-labelled peak III is homogenous and comparable in YH. 16 .33 (Fig. 2a) and MVB2 (Fig. 2b) cells per assay) was determined at 15°C for 1 h using '25l-insulin as described in [11] ; the insulin concentration in the assay was 82,tM. Mono-'251-insulin with a specific radioactivity of 240-300 ,tCi/,ug was prepared as in [16] . far elucidated indicates a strict conservation of a phosphatidylinositol-glucosamine-(mannose)3-phosphoethanolamine core among them [17, 18] . Rat brain Thy-I anchor has an extra phosphoethanolamine and several additional mannosyl residues [19] . Different chemical compositions of insulin-sensitive glycosyl-Ptdlns and IPG have been reported [20] [21] [22] . In H35 cells and rat liver membranes a compound has been described which contains phospho-chiro-inositol linked glycosidically to one glucosaminyl and several additional galactosyl residues [21] .
Analysis of the chemical composition of glucosamine-containing peak III was performed by metabolic labelling. YH. 16 .33 and MVB2 cells (1 x 105) were labelled by a 24 h incubation with the various precursors, and at the end of this period lipids were extracted and peak III was purified using the acid/base t.l.c. system described in Fig. 1 . A comparison between the quantities of 3H-labelled peak III recovered after labelling of the cells for 24 or 48 h indicated that the labelling with the various precursors was at equilibrium after 24 h. In all experiments, control cells were labelled with [3H]glucosamine and the [3H]glucosaminelabelled peak III was purified in parallel with the samples containing the other labels. As shown in Table 1 , selectivity of fatty acid incorporation was observed. The highest incorporation was obtained with myristic acid (C14:0), followed by palmitic acid (C16:0). Little label was recovered when arachidonic acid (C20:4) was used. There were no significant differences in the degree of incorporation between the mutant MVB2 and the wild-type YH. 16 .33 cells. The heterogeneous fatty acid composition of the glycosyl-PtdIns purified from T-T hybrids agrees with that reported for T-lymphocytes [11] . However, this is in contrast with results from other cell lines and sources [9, 20, 21] .
As also shown in [6] , YH. 16 .33 but not MVB2 cells were able to incorporate both radioactive precursors into proteins with the same molecular masses as TAP and Thy-I (results not shown).
The synthesis of the major structural phospholipids was also studied in the two cell lines. A good incorporation of choline into phosphatidylcholine, ethanolamine into phosphatidylethanolamine and serine into phosphatidylserine was observed under the conditions of labelling, indicating that the precursors were entering the cells. The ratio of choline incorporation into PtdChol/glucosamine incorporation into glycosyl-Ptdlns was 118.9 in YH. 16 .33 cells and 117.7 in the mutant MVB2 cell line. Similar ratios between the two cell lines were found when serine or ethanolamine incorporation into their respective phospholipids was compared with glucosamine or palmitic acid incorporation into glycosyl-Ptdlns, indicating that MVB2 cells do not show significant alterations in phospholipid metabolism.
To further characterize peak III, its sensitivity to nitrous acid deamination and to Ptdlns-PLC was tested in cells pre-labelled with [3H]glucosamine for 24 h as described in [8] . Phospholipase treatment was carried out using either B. cereus or B. thuringiensis Ptdlns-PLC, for 2 h at 37 'C. The amount of [3H]glycosyl-Ptdlns recovered over the total period was about 24 % and 650 respectively. These data suggest that the glycosyl-Ptdlns recovered in peak III might be heterogeneous, despite the fact that it migrates as a single peak in one-and two-dimensional t.l.c. No differences were observed in glycosyl-Ptdlns sensitivity to phospholipase between the wild-type and the mutant cells. These results indicate that peak III glycolipid contains Ptdlns, despite the failure to find myo-inositol labelling under conditions where other precursors were incorporated. This discrepancy may be explained by the presence of different inositol isomers in peak III, as has been described in H35 hepatoma cells and rat liver membranes [21, 22] . Nitrous acid treatment indicted that peak III purified from either cell line was cleaved by about 200%. The glycosyl-PtdIns sensitivity to acid deamination previously reported varied greatly among the sources used [9, 11, 12] .
In conclusion, glycosyl-PtdIns purified from MVB2 cells has all the same characteristics as the lipid purified from YH. 16 .33 that we have been able to assay for.
Localization of glycosyl-Ptdlns at the plasma membrane TAP and Thy-1 molecules are absent from the cell surface of MVB2 mutants, but there is a normal expression of other T-cell surface proteins [6] . MVB2 cells synthesize low-molecular-mass forms of TAP and Thy-1 proteins which lack the lipid moiety present on the membrane forms of the corresponding wild-type proteins. Insulin-sensitive glycosyl-Ptdlns has been localized at the outer surface of human lymphocytes by a combination of chemical labelling and enzymic modifications with ,J-galactosidase and Ptdlns-PLC [14] .
A similar approach was used to study whether the final localization of glycosyl-Ptdlns was affected in MVB2 mutants. [23, 24] , including T-lymphocytes [11] .
To determine the effect of insulin on glycosyl-Ptdlns hydrolysis, 1 X 105 YH. 16 .33 and MVB2 cells were labelled with [3H]-glucosamine for 24 h to achieve steady-state labelling of glycosylPtdlns. Cells were then washed into insulin-free medium for 90 min, after which reactions were initiated by the addition of 1 nM-insulin. Incubations were carried out for the times indicated in Fig. 3 , and glycosyl-Ptdlns levels were determined. The addition of insulin to T-T hybrid wild-type cells led to the loss of about 54 % of the glycosyl-Ptdlns within 30 s. The MVB2 cells responded by hydrolysing 61 % of the glycolipid, with the same fast and reversible time course (Fig. 3) . Resynthesis of glycosylPtdlns began rapidly thereafter, and by [4] [5] 
Biological activity of IPG
Insulin-dependent hydrolysis of glycosyl-Ptdlns by Ptdlns-PLC liberates its polar head group, IPG, which displays a variety of insulin-like actions and has been proposed as a mediator of insulin action (for reviews see [3] and [25] ). The biological Vol. 282 activity of IPG from T-T hybrid cells was assessed in vitro by testing its capacity to inhibit the phosphorylation of histone IIA by the cyclic AMP-dependent protein kinase, as described previously [26] . IPG was prepared by hydrolysis with bacterial PtdIns-PLC of glycosyl-Ptdlns purified from either YH. 16 .33 or MVB2 cells (1 x 108 cells) as in [15] . The concentration of IPG was calculated by measuring free amino groups, assuming that each molecule of IPG contains one amino group [14] . The addition of IPG (10 /uM), purified from YH. 16.33 or MVB2 cells, to the protein kinase A assay caused respectively 76 % and 83 % inhibition of the kinase activity over 10 min. The incorporation of 32P into washed histone IIA in control samples was about 41000 c.p.m., and the experiment was performed twice in duplicate. These data indicate that both the Ptdlns-anchor-deficient mutant and the wild-type T-T hybrid possess a fully active IPG.
